You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
熱景生物(688068.SH):擬出資5800萬元設立控股子公司 以受讓“外泌體相關基因檢測研發項目”
格隆匯 09-15 16:55

格隆匯9月15日丨熱景生物(688068.SH)公佈,公司擬與林長青、員工持股平台北京堯景企業管理中心(有限合夥)(“堯景管理中心”,最終名稱以工商登記為準)共同出資1億元人民幣設立北京堯景基因技術有限公司(“堯景基因”、“標的公司”),其中公司擬以自有資金出資人民幣5800萬元,持股58.00%;林長青出資人民幣2200萬元,持股22.00%;堯景管理中心(有限合夥)出資人民幣2000萬元,持股20.00%。

堯景基因成立後,擬按照研發項目累計已發生賬面原值購買公司“外泌體相關基因檢測研發項目”。截止2021年8月31日累計已發生的研發費用賬面發生額確定轉讓價格,金額為248.19萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account